Literature DB >> 2160237

Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.

R Seifert1, G Schultz, M Richter-Freund, J Metzger, K H Wiesmüller, G Jung, W G Bessler, S Hauschildt.   

Abstract

Upon exposure to the bacterial chemotactic peptide fMet-Leu-Phe, human neutrophils release lysozyme and generate superoxide anions (O2.-). The synthetic lipoamino acid N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-(R)-cysteine (Pam3Cys), which is derived from the N-terminus of bacterial lipoprotein, when attached to Ser-(Lys)4 [giving Pam3Cys-Ser-(Lys)4], activated O2.- formation and lysozyme release in human neutrophils with an effectiveness amounting to about 15% of that of fMet-Leu-Phe. Palmitic acid, muramyl dipeptide, lipopolysaccharide and the lipopeptides Pam3Cys-Ala-Gly, Pam3Cys-Ser-Gly, Pam3Cys-Ser, Pam3Cys-OMe and Pam3Cys-OH did not activate O2.- formation. Pertussis toxin, which ADP-ribosylates guanine-nucleotide-binding proteins (G-proteins) and functionally uncouples formyl peptide receptors from G-proteins, prevented activation of O2.- formation by fMet-Leu-Phe and inhibited Pam3Cys-Ser-(Lys)4-induced O2.- formation by 85%. Lipopeptide-induced exocytosis was pertussis-toxin-insensitive. O2.- formation induced by Pam3Cys-Ser-(Lys)4 and fMet-Leu-Phe was enhanced by cytochalasin B, by a phorbol ester and by a diacylglycerol kinase inhibitor. Addition of activators of adenylate cyclase and removal of extracellular Ca2+ inhibited O2.- formation by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 to different extents. Pam3Cys-Ser-(Lys)4 synergistically enhanced fMet-Leu-Phe-induced O2.- formation and primed neutrophils to respond to the chemotactic peptide at non-stimulatory concentrations. Our data suggest the following. (1) Pam3Cys-Ser-(Lys)4 activates neutrophils through G-proteins, involving pertussis-toxin-sensitive and -insensitive processes. (2) The signal transduction pathways activated by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 are similar but not identical. (3) In inflammatory processes, bacterial lipoproteins and chemotactic peptides may interact synergistically to activate O2.- formation, leading to enhanced bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160237      PMCID: PMC1131368          DOI: 10.1042/bj2670795

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  A wasp venom mastoparan-induced polyphosphoinositide breakdown in rat peritoneal mast cells.

Authors:  Y Okano; H Takagi; T Tohmatsu; S Nakashima; Y Kuroda; K Saito; Y Nozawa
Journal:  FEBS Lett       Date:  1985-09-02       Impact factor: 4.124

Review 2.  The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function.

Authors:  F Rossi
Journal:  Biochim Biophys Acta       Date:  1986-11-04

3.  Basic methods for the study of phagocytosis.

Authors:  D R Absolom
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes.

Authors:  A J Jesaitis; J O Tolley; R A Allen
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

5.  Guanine nucleotides stimulate NADPH oxidase in membranes of human neutrophils.

Authors:  R Seifert; W Rosenthal; G Schultz
Journal:  FEBS Lett       Date:  1986-09-01       Impact factor: 4.124

6.  Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors.

Authors:  R Burde; R Seifert; A Buschauer; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  Fatty-acid-induced activation of NADPH oxidase in plasma membranes of human neutrophils depends on neutrophil cytosol and is potentiated by stable guanine nucleotides.

Authors:  R Seifert; G Schultz
Journal:  Eur J Biochem       Date:  1987-02-02

8.  Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.

Authors:  W G Bessler; M Cox; A Lex; B Suhr; K H Wiesmüller; G Jung
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet.

Authors:  D C de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

10.  The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.

Authors:  F Melchers; V Braun; C Galanos
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  10 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

3.  Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.

Authors:  Inga Wilde; Sonja Lotz; David Engelmann; Andrea Starke; Ger van Zandbergen; Werner Solbach; Tamás Laskay
Journal:  Med Microbiol Immunol       Date:  2006-09-28       Impact factor: 3.402

Review 4.  Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.

Authors:  Michael R Batzloff; Manisha Pandey; Colleen Olive; Michael F Good
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  [Lipopeptides as natural adjuvants for vaccines from Gram-negative bacteria].

Authors:  S Schlecht; K H Wiesmüller; G Jung; W G Bessler
Journal:  Naturwissenschaften       Date:  1993-01

6.  Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation.

Authors:  Hartmut Stoll; Jörn Dengjel; Christiane Nerz; Friedrich Götz
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase.

Authors:  J F Klinker; A Hagelüken; L Grünbaum; I Heilmann; B Nürnberg; R Harhammer; S Offermanns; I Schwaner; J Ervens; K Wenzel-Seifert
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

8.  Lipopeptides activate Gi-proteins in dibutyryl cyclic AMP-differentiated HL-60 cells.

Authors:  J F Klinker; A Höer; I Schwaner; S Offermanns; K Wenzel-Seifert; R Seifert
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Synergistic stimulation of human B lymphocytes by anti-CD40 monoclonal antibodies and synthetic lipopeptide analogues from Escherichia coli lipoprotein.

Authors:  M Edinger; W G Bessler; B Kleine
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro.

Authors:  F Tamarozzi; H L Wright; K L Johnston; S W Edwards; J D Turner; M J Taylor
Journal:  Parasite Immunol       Date:  2014-10       Impact factor: 2.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.